Impraliv-SP Tablet is a combination analgesic and anti-inflammatory medication containing Diclofenac 50 mg, Paracetamol 325 mg, and Serratiopeptidase 15 mg. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), provides potent anti-inflammatory, analgesic, and antipyretic effects by inhibiting cyclooxygenase enzymes, thereby reducing prostaglandin synthesis. Paracetamol complements this action with its central analgesic and antipyretic properties, enhancing pain relief while minimizing gastrointestinal irritation commonly associated with NSAIDs. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory exudates and promotes the resolution of inflammation and edema, contributing to improved tissue healing and reduced swelling. This synergistic combination is indicated for the management of acute and chronic musculoskeletal pain, post-operative pain, dental pain, arthritis, and other inflammatory conditions. Impraliv-SP Tablet is effective in reducing pain, inflammation, and associated symptoms, thereby improving patient comfort and mobility. It should be used under medical supervision, with caution advised in patients with a history of gastrointestinal ulcers, hepatic or renal impairment, and hypersensitivity to any component. The dosage regimen should be individualized based on clinical response and tolerability.